BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Waldenstrom's Macroglobulinemia readouts · AssetMemo
X-WR-CALDESC:Upcoming phase 1/2 and later readouts in Waldenstrom's Macrogl
 obulinemia\, from ClinicalTrials.gov estimates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07766421-3317@assetmemo.bio
DTSTAMP:20261121T004947Z
DTSTART;VALUE=DATE:20320131
DTEND;VALUE=DATE:20320201
SUMMARY:Iopofosine I-131: Phase 3 readout est. (NCT07766421)
DESCRIPTION:Iopofosine I-131\, phase 3\, Waldenstrom's Macroglobulinemia.\n
 Study: Evaluation of Iopofosine I 131 vs. R-CD in WM Patients\nEstimated p
 rimary completion: January 2032. This is a ClinicalTrials.gov estimate\, n
 ot a confirmed readout date\, and it can move.\nDrug page: https://assetme
 mo.bio/drug/iopofosine-i-131#upcoming-events\nRegistry record: https://cli
 nicaltrials.gov/study/NCT07766421
URL:https://assetmemo.bio/drug/iopofosine-i-131#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
